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Introduction {#sec1}
============

Investigation into the role of microglia, the myeloid cells that reside in the CNS, has begun to receive intense interest, unravelling the complexity of the effects that these cells have on neural functions and establishing their major role in the development and life-long maintenance of brain homeostasis ([@bib20], [@bib34], [@bib37]).

During development, microglia have been shown to influence neurodevelopmental processes such as axon guidance, neurite growth, and synaptic pruning ([@bib18], [@bib38], [@bib50]), and to follow a precise and coordinated transcriptional program ([@bib25]). In addition, it has been demonstrated that microglia participate in the process of brain masculinization induced by the neonatal surge of male gonadal activity ([@bib23]); this process organizes brain architecture by structuring neuronal circuits to be activated by sexual functions after puberty ([@bib1], [@bib24]). In adults, microglia are the first line of protection against noxious stimuli such as stress and pathogenic insults, and they maintain healthy brain function by pruning synapses ([@bib18], [@bib50]), clearing debris ([@bib31]), and synthesizing growth and repair factors ([@bib17]). In spite of this, prolonged microglia stimulation may lead to neuronal damage. Indeed, several recent studies have highlighted the involvement of microglia and neuroinflammation in the manifestation of major neurological and neuropsychiatric diseases.

The finding that these cells are responsive to estrogens and that their immune functions and inflammatory response are significantly mitigated by estrogens ([@bib45]) may point to a role of this hormone in determining the sex-specific prevalence, onset, and course of numerous brain diseases ([@bib46], [@bib48]). Furthermore, increasing evidence suggests that neurological disorders have their roots in diversions from a normal developmental trajectory, and disturbances and a loss of microglial function have been associated with the onset of brain diseases ([@bib34]). Considering the role of microglia in brain sexual differentiation, it could be hypothesized that the effects of estrogens during brain differentiation may induce permanent effects in microglia, enabling these cells to contribute to sex-related manifestation of brain diseases ([@bib48]).

The aim of the present study was to identify the differences in the transcriptome of male and female microglia isolated from adult healthy mice and to verify the extent to which microglia sex differences might affect the progress of pathologies where these immune cells play a major role.

Results {#sec2}
=======

RNA-Sequencing Highlights Sex Differences in Adult Microglia {#sec2.1}
------------------------------------------------------------

To study the expression profile of male and female microglia, we took advantage of a recently developed methodology to isolate these cells at high level of purity from adult brain ([@bib15], [@bib33]) ([Figure S1](#mmc1){ref-type="supplementary-material"}A--S1D). To avoid the variability related to rearing, environment, or diets affecting the metabolism and the microbiome, both well-known regulators of the brain immune system ([@bib16]), care was taken to match the mice in terms of age and to take the same number of males and females from each of the litters utilized in the study. To limit any circadian influence and facilitate the analysis of the phase of the cycle, in all experiments, animals were euthanized at the same hours (between 2:00 and 4:00 p.m.); females were at metestrus, a phase with low circulating estrogens.

The transcriptome was investigated by RNA sequencing (RNA-seq; RNA-seq data are available at the NCBI Sequence Read Archive: SRP104620). The RNAs were prepared from pools of 6 brains each: 2 pools were from males and 2 pools from females; thus, we utilized a total of 12 mice/sex. Mice were 12 weeks old. The transcriptional data were initially analyzed by AltAnalyze ([@bib32]) and mapped over the Tissue Fate Map to demonstrate the absence of contaminations from other neural cells. Indeed, the reads per kilobase million (RPKM) relative to biomarkers of neutrophils (*Ly6g*), B cells (*Cd19*), T cells (*Cd3*--*Cd8*), astrocytes (*Aldh1l1*), neurons (*Thy1*), and oligodendrocytes (*Olig1*) were found to be negligible with respect to the predominant microglia markers.

To determine the differently expressed genes (DEGs), we carried out the statistical analysis using the CuffDiff ([@bib42]) software. By applying a threshold of 0.01 to the false discovery rate (FDR; Benjamini-Hochberg correction)-adjusted p values (pVal), we identified 546 DEGs ([Figure 1](#fig1){ref-type="fig"}A). The reliability of the RNA-seq results was tested on microglia isolated from 12 additional individuals (males, n = 6; females, n = 6); the results obtained with qPCR on a panel of 20 mRNAs randomly selected among those with sex-dependent and sex-independent expression demonstrated the reproducibility of the RNA-seq data ([Figure S1](#mmc1){ref-type="supplementary-material"}E).Figure 1Microglia Transcriptome in the Male and Female Mouse Brain(A) Volcano plot of RNA-seq data obtained from microglia isolated from male and female adult C57BL/6 mice. Analyses were conducted on two pools of six brains each, a total of 12 males and 12 females. Blue dots represent genes for which RPKM values are significantly higher in males than in females (204 genes; p \< 0.01 by Benjamini-Hochberg correction). Red dots represent genes for which RPKM values are significantly higher in females than in males (342 genes; p \< 0.01).(B) Gene Ontology and ChIP enrichment analysis (ChEA) transcription factor (TF) term enrichment analysis of transcripts with higher expression in male (blue) or in female (red) microglia.(C) *In vivo* imaging of luciferase expression in male and female NFκB-*luc2* mice. Bioluminescence is measured ventrally and whole body, and the pseudocolors represent radiance (p/s/cm^2^/sr). The image is representative of three independent measures on three mice per group per experiment. In the graph, each line corresponds to average radiance ± SEM.(D) Luciferase activity measured in extracts of microglia isolated from the whole brains of male (n = 3) and female (n = 3) NFκB-*luc2* mice and expressed as relative luciferase units (RLUs) per microgram of proteins. Each sample was measured in triplicates. Lines represent the mean ± SEM of n = 3. ^∗^p \< 0.05 by unpaired, two-tailed t test.

Next, to identify whether the DEGs could be associated with specific functional categories, we carried out a clustering analysis by Enrichr ([@bib21]). The majority of the 204 genes more expressed in males belonged to Gene Ontology classes associated with inflammatory processes, including regulation of cell migration and cytokine production ([Figure 1](#fig1){ref-type="fig"}B). Whole-genome molecular signature analysis of transcription factors (TFs) pointed to nuclear factor κB (NF-κB) as the TF most involved in the regulation of the DEG preferentially expressed in males, together with other TFs associated with inflammatory processes (RUNX1) ([@bib19]), migration (FOXM1) ([@bib2]), and negative regulation of neurogenesis (GATA2) ([@bib8]). In contrast, no association with inflammation was found in the DEGs distinctive of female microglia that were grouped in ontogenies associated with morphogenesis, development, or cytoskeleton organization under the control of several TFs such as NANOG ([@bib7]) and TCF3 ([@bib29]), linked to the inhibition of inflammatory response and promotion of repair mechanisms ([@bib7], [@bib29]), aside from the estrogen receptor alpha (ESR1) itself. The lack of a sex-dependent pro-inflammatory profile in macrophages isolated from the peritoneum of the male mice studied above (G.P. and E.V., unpublished data) suggested that this could be a microglia-specific feature.

The Inflammatory Phenotype of Male Microglia {#sec2.2}
--------------------------------------------

We continued our study in the NFκB-*luc*2 mouse model where the luciferase gene was under the control of an NF-κB-responsive synthetic promoter. This reporter mouse was specifically designed to study the inflammatory status in living cells and animals ([@bib35]). Whole-body, *in vivo* imaging in unstimulated conditions showed that the bioluminescence was comparable in siblings of the two sexes (n = 3) ([Figure 1](#fig1){ref-type="fig"}C); this result suggested a similar, generalized state of NF-κB transcriptional activation in males and females. However, when we measured luciferase activity in microglia purified from adult siblings of both sexes (n = 3), the luciferase activity was 2.4-fold higher in males ([Figure 1](#fig1){ref-type="fig"}D). These data supported our previous bioinformatic analysis by demonstrating that in male microglia NF-κB was transcriptionally activated, suggesting that male microglia cells were more poised to inflammatory reactions than female microglia. To substantiate the hypothesis of male microglia more prone to inflammatory activation, we further analyzed the RNA-seq data, focusing on a total of 95 genes that had been experimentally demonstrated to be targets of NF-κB and involved in immune or inflammatory responses (<http://www.bu.edu/nf-kb/gene-resources/target-genes/>).

Consistent with previous results, unbiased male-female comparative analysis ([Figure 2](#fig2){ref-type="fig"}A) showed that 79% of the 95 inflammatory genes were more expressed in males, and 34 of these genes were differentially expressed with a threshold of 0.05 applied to the FDR (Benjamini-Hochberg correction)-adjusted p values (clusters D, E, and F); of the remaining genes, 14% were expressed similarly in the two sexes (clusters B and C), and 7% were grouped in cluster A, possibly for having a trend to be more expressed in females.Figure 2The Role of Estrogens in Preventing Microglia Inflammatory Phenotype(A) Heatmap and hierarchical clustering of expression profiles for a subset of NF-κB-regulated genes measured in microglia, isolated from adult C57BL/6 mice: males, intact females (Cyc Met), and ovariectomized females treated with vehicle (OVX) or 17β-estradiol for 3 hr (OVX + E~2~ 3 hr) and 24 hr (OVX + E~2~ 24 hr). The group size was n = 2 samples per condition, each sample consisting of a pool of six brains. The results were log-transformed, normalized, and centered, and populations and genes were clustered by Pearson correlation. Data were obtained from two pools of six brains each. The right panel shows general expression plots for each cluster. The purple line represents the mean expression of the clustered genes.(B) Immunocytochemistry of microglia stained with Iba1 antibody (red signal) showing different phenotypes in males or females. Upper panel: details of microglia (×100 magnification); lower panel: lower magnification images (×20) including neurons expressing EGFP (green). In the graph, each column corresponds to the percentage of cells showing either the resting or the activated phenotype. We blind-counted the cells present in 18 ×20 images (for about 200 cells/sex in total). The blind count was repeated by three different operators. ^∗^p \< 0.05 by unpaired, two-tailed t test. Scale bar: 10 μm.(C and D) qPCR analyses of genes showing higher expression in male (C) or female (D) microglia. Data are expressed as 2^−ΔΔCt^ using the 36B4 transcript as an internal reference standard. Each column represents the mean ± SEM of n = 6 plates measured in triplicate. ^∗^p \< 0.05; ^∗∗^p \< 0.01 by a one-way ANOVA and Tukey's method for multiple comparisons versus expression in neurons + male microglia (blue column).

Is Circulating 17β-Estradiol Responsible for Microglial Sex Differences? {#sec2.3}
------------------------------------------------------------------------

To investigate the extent to which estrogens contributed to the sex differences observed in the NF-κB-regulated genes, we extended the analysis to the RNA-seq data on microglia isolated from mice ovariectomized (OVX) with or without estrogen replacement for 3 or 24 hr; such data were generated using groups of animals reared and treated in parallel with those described above. After ovariectomy, we observed a tendency toward a reduction in differences between the two sexes, with a generalized increase in the expression of the 95 NF-κB-driven genes ([Figure 2](#fig2){ref-type="fig"}A). However, Pearson analysis did not show significant changes when we did correlation analyses between the NF-κB genes expressed in OVX females/males (R = 0.9327) and cycling females/males (R = 0.8589), leading us to conclude that the gene expression of microglia was not significantly influenced by the lack of circulating sex steroids. Moreover, in the OVX mice, 17 of the original 34 DEGs were still found to be less expressed (with a threshold of 0.05 applied to the adjusted p values) than in males despite the lack of circulating estrogens; this finding pointed to the contribution of factors other than estrogens to the low expression of NF-κB-regulated genes. Hormone replacement induced a trend in the expression of these genes; hierarchical clustering (Pearson correlation, average linkage) identified three clusters of genes for which estrogen administration induced a rapid, transient increase (78%, clusters B, D, and F; [Figure 2](#fig2){ref-type="fig"}A), and a smaller group of genes (22%, clusters A, C, and E) showed the opposite trend, with a decreased expression after 3 hr of 17β-estradiol (E~2~) treatment.

These findings suggested that the transcriptional differences of the NF-κB-regulated genes did not depend on estrogens in a predictable way, and that additional factors played a role in differentiating the male and female microglia transcriptomes.

To evaluate whether the sex differences observed were maintained *in vitro*, we prepared primary cultures of microglia isolated from adult male and female mice. To enable microglia to survive and to preserve their responsiveness to inflammatory stimuli, the adult microglia cells were co-cultured with neurons dissected from hippocampi of rat embryos differentiated to mature neurons with \>98% homogeneity ([@bib11]). Bias of the co-culture was avoided by using a mix of male and female neurons.

Morphological analysis of microglia in culture ([@bib3]) showed significant sex differences: 75% of male microglia had the globular morphology associated with the pro-inflammatory phenotype, and the remaining had the ramified branches connected with the surveilling status; in females, the percentage of activated microglia cells was much lower (50%) ([Figure 2](#fig2){ref-type="fig"}B). Consistent with this observation, qPCR on a subset of DEGs showed that the microglia grown in culture preserved, by and large, the expression pattern of the sex of origin ([Figures 2](#fig2){ref-type="fig"}C and 2D). Thus, microglia in culture appeared to maintain a gene expression characteristic of the sex of origin.

Female Microglia Retain Their Sex after Transplantation in the Male Brain {#sec2.4}
-------------------------------------------------------------------------

To better demonstrate that the transcriptome of adult microglia was sexually differentiated and independent of the *in vivo* hormonal environment, we investigated the gene expression profile of female microglia after transplantation into a male brain. In designing the transfer experiment, we anticipated several potential limitations, such as host versus graft reactions, microglia viability, and the ability to proliferate and migrate throughout the host brain. To facilitate the host brain repopulation by the transplanted microglia and limit adverse reactions, we first depleted the endogenous microglia. Previous reports had demonstrated that PLX3397, a small-molecule inhibitor of the CSF1 receptor (CSF1R) and related kinases, was able to promote selective microglia apoptosis ([@bib9]). This effect was transient, and microglia started to proliferate upon cessation of the treatment ([@bib9]). We administered PLX3397 via the transnasal (tsn) route to improve its permeation and diffusion throughout the brain parenchyma. Dose-response experiments allowed the identification of 100 μg/*die* as the minimum effective dose of PLX3397 necessary to deplete \>90% of microglia after 7 days of treatment; no sign of toxicity was observed at higher dosages (data not shown). To be sure to maintain effective concentrations of PLX3397 in the brain, we treated the mice with 100 μg twice a day. The efficacy of the treatment was measured by the following: (1) counting the cells that were isolated from a single brain ([Figure S2](#mmc1){ref-type="supplementary-material"}A); (2) measuring the whole brain content of the mRNA encoding the complement C1q subcomponent subunit A (C1qa), constitutively expressed in microglia ([@bib10]) ([Figure S2](#mmc1){ref-type="supplementary-material"}B); and (3) flow cytometry ([Figure S2](#mmc1){ref-type="supplementary-material"}C). As reported previously in the literature ([@bib9]), at day 7, only a very small percentage (\<8%) of the endogenous microglia was spared by the treatment; interruption of drug administration resulted in a rapid microglia proliferation starting 24 hr after the end of treatment, and 5 days after ending PLX3397 administration, the brain content of microglia cells was back to normal ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Having established the procedure to eliminate the majority of the host microglia, we proceeded with the transplantation using microglia purified from female UBC-*luc2* (G4063), a transgenic mouse model where the expression of the luciferase reporter is constitutive and not affected by sex and age ([@bib35]). Prior to cell transplantation, we showed that in the isolated microglia, the light emission was directly proportional to the cell number ([Figure S2](#mmc1){ref-type="supplementary-material"}D). For the cell transfer, we avoided brain injections and opted for the tsn route to preserve brain inflammatory homeostasis and blood-brain barrier integrity. A total number of 350,000--400,000 female bioluminescent microglia cells were tsn-transferred to the microglia-depleted male brains 24 hr after the interruption of PLX3397 treatment. The tsn administration enabled the distribution of cells throughout the forebrain and the caudal brain, including the brainstem and cerebellum (see [Figure S2](#mmc1){ref-type="supplementary-material"}E and its legend). *Ex vivo* imaging ([@bib41]) established that 3 days after the tsn administration, the bioluminescent exogenous microglia cells were located mainly in the cortex ([Figure 3](#fig3){ref-type="fig"}A). This was expected on the basis of the route of administration selected ([Figure S2](#mmc1){ref-type="supplementary-material"}E). At day 5, the significant increase of bioluminescence indicated that the transplanted female microglia were actively proliferating; furthermore, these cells had spread in most brain areas including the cortex, hippocampus, caudate and putamen, thalamus, hypothalamus, mid-brain, and pons ([Figure S2](#mmc1){ref-type="supplementary-material"}F). The presence in the recipient male brain of an mRNA that is exclusively expressed in females, the X-inactive specific transcript (*Xist*), demonstrated that the transfer experiment had been successful ([Figure 3](#fig3){ref-type="fig"}C). In addition, the exogenous microglia were alive and transcriptionally active because the amount of *Xist* mRNA detectable 3 days after the transfer was increased at day 5 ([Figure 3](#fig3){ref-type="fig"}C). At day 5, the ratio of *Xist* to *C1qa* mRNAs indicated that the transplanted female cells were approximately 19% of the total host brain microglia ([Figure 3](#fig3){ref-type="fig"}C); this amount was confirmed by flow cytometry of CX3CR1-GFP male microglia transplanted in wild-type (males or females) ([Figure S2](#mmc1){ref-type="supplementary-material"}G); the same experiment allowed to demonstrate that the transplanted cells maintained the expression of microglia-specific biomarkers (Tmem119) ([@bib4]) ([Figure S2](#mmc1){ref-type="supplementary-material"}H). Further experiments with female or male microglia transplanted into male recipients (F/M or M/M, respectively) established that the sex of origin did not influence the ability of these cells to proliferate; indeed, [Figure 3](#fig3){ref-type="fig"}D shows that the expressions of selected genes (*C1qa* marker of total microglia content, *Ki67* associated with cell proliferation, and *Cdk3* expressed during G0--G1 and G1--S cell-cycle transitions) was the same in male or female transplanted cells. To investigate the extent to which the transplanted microglia preserved their sex-specific identity, we transplanted fluorescent microglia (from male or female CX3CR1-GFP mice) in WT males and analyzed the expression of selected genes in the fluorescent cells isolated by FACS. Male fluorescent cells transplanted in males (M/M) maintained the male-specific (M) profile of expression (relatively high *Akt1s1*, *Trem1*, *S100a9*, and *Cxcl2* and low *Shank3*, *Fxyd1*, *Aqp1*, and *Timp3*); female cells transplanted in males (F/M) were able to keep a profile of expression superimposable with that of the control females (F) ([Figures 3](#fig3){ref-type="fig"}E and 3F).Figure 3Female Microglia Maintain Their Characteristic Gene Expression When Transplanted in Male Brain(A) Bioluminescence-based optical imaging of brain slices of WT male mice before (left panel) and after (3 days, central panel; 5 days, right panel) transnasal administration of 400,000 bioluminescent microglial cells isolated from female G4063 mice; pseudocolors represent the intensity of light emission (p/s/cm^2^/sr). The images are representative of three independent measures on n = 3 individual animals/group.(B) Three-dimensional representation of the distribution of bioluminescent signals in WT mouse brain, 5 days after transnasal administration of bioluminescent microglial cells isolated from G4063 mice. Pseudocolors represent the intensity of light emission (p/s/cm^2^/sr), according to the color bar reported in (A).(C) RT-PCR analysis was performed using primers for Xist mRNA (amplicon: 124 bp) on microglia RNA isolated from naive male (M) or female (F) mice, vehicle-treated male mice (Veh, 5 days \[5d\]) or after transnasal administration of 400,000 microglial cells isolated from female C57BL/6 mice (F/M 3d: microglia isolated 3 days after transnasal administration; F/M 5d: microglia isolated 5 days after transnasal administration). Bars represent the percentage ratio of Xist and C1qa mRNA accumulation in naive female microglia (two independent measures, n = 3) or in microglia derived from males, 5 days after transnasal administration of 400,000 microglial cells isolated from female C57BL/6 mice (5d: microglia isolated 5 days after transnasal administration, two independent measures, n = 3). Data are normalized to naive female mice.(D) qPCR analyses of C1qa, Xist, Ki67, and Cdk3 mRNA accumulation in microglia isolated from naive female (F) or male (M) mice or 5 days after transnasal administration of 400,000 microglial cells isolated from female (F/M) or male (M/M) C57BL/6 mice. Data are expressed as 2^−ΔΔCt^ using the 36B4 transcript as an internal reference standard. Columns represent the mean ± SEM of n = 6 animals measured in triplicates. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 by a one-way ANOVA and Tukey's method for multiple comparisons versus (F). ^\#^p \< 0.05 by a two-way ANOVA and Tukey's method for multiple comparisons.(E) qPCR analyses of Shank3, Fxyd1, Aqp1, and Timp3 mRNA accumulation in microglia isolated from naive female (F) or male (M) mice or fluorescence-sorted 5 days after transnasal administration of 400,000 microglial cells isolated from female (F/M) or male (M/M) CX3CR1-GFP mice. Data are expressed as 2^−ΔΔCt^ using the 36B4 transcript as an internal reference standard. Columns represent the mean ± SEM of n = 6 animals measured in triplicates. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 by a one-way ANOVA and Tukey's method for multiple comparisons versus (F). ^\#^p \< 0.05 by a two-way ANOVA and Tukey's method for multiple comparisons.(F) qPCR analyses of Akt1s1, Trem1, S100a9, and Cxcl2 mRNA accumulation in microglia isolated from naive female (F) or male (M) mice or fluorescence-sorted 5 days after transnasal administration of 400,000 microglial cells isolated from female (F/M) or male (M/M) CX3CR1-GFP mice. Data are expressed as 2^−ΔΔCt^ using the 36B4 transcript as an internal reference standard. Columns represent the mean ± SEM of n = 6 animals measured in triplicates. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 by a one-way ANOVA and Tukey's method for multiple comparisons versus microglia isolated from naive female mice. ^\#^p \< 0.05; ^\#\#\#^p \< 0.001 by a two-way ANOVA and Tukey's method for multiple comparisons.(G) qPCR analyses of Akt1s1, Trem1, S100a9, and Cxcl2 mRNA accumulation in microglia isolated from naive male (♂), female (♀), or masculinized female (⚥) C57BL/6 mice. Data are expressed as 2^−ΔΔCt^ using the 36B4 transcript as an internal reference standard. Columns represent the mean ± SEM of n = 6 animals measured in triplicates. ^∗^p \< 0.05 by a one-way ANOVA and Tukey's method for multiple comparisons versus ♂.

The combination of all the experiments conducted highlighted the possibility of a genomic and/or epigenetic component that sexually differentiates microglia gene expression. It is known that the perinatal androgen surge from male testis and the subsequent local aromatization of testosterone to estradiol is crucial for the permanent modification of neuronal functions characteristic of brain masculinization ([@bib1], [@bib27], [@bib48]). In line with these reports, imaging experiments on ERE-Luc mice showed that perinatal activation of ERα is restricted to males ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). To directly show that in addition to neurons the perinatal exposure to estrogens could affect microglia gene expression permanently, we followed a classical protocol of brain masculinization by treating male and female pups with E~2~ benzoate at days P2, P5, and P8 ([@bib26], [@bib49]). The masculinized females were unable to cycle at 6--8 weeks of age, demonstrating the efficacy of the protocol. The extent to which the treatment had affected microglia gene expression was assessed by qPCR of the four DEGs previously identified as more expressed in males. [Figure 3](#fig3){ref-type="fig"}G shows that in the microglia extracted from the masculinized brains, the expression of *Akts*, *Trem1*, and *CxCl2* was not significantly different than in males; *S100a9* was not affected by the brain masculinization.

Protective Action of Female Microglia in Ischemia {#sec2.5}
-------------------------------------------------

We next asked whether microglia sex-specific gene expression had any functional relevance. Several authors demonstrated that in the case of forebrain or focal ischemia, young adult female rodents sustain smaller injury than males, and females have lower mortality than males ([@bib30], [@bib40]). The course of microglia activation after cerebral ischemia has been largely described, and it is well known that microglia proliferation at the infarct site limits the ischemic damage possibly because microglia generate neurotrophic factors that are beneficial for neuronal plasticity ([@bib22]). Considering this fact, and based on the results obtained with our RNA-seq analyses that unstimulated female microglia have a higher propensity than male microglia to express genes involved in cell plasticity, the control of the inflammatory response, and repair mechanisms, we questioned whether transferring female microglia into male brains would have restricted the brain damage consequent to ischemia. First, we subjected adult WT male (n = 6) and female (n = 6) mice to permanent focal cerebral ischemia (permanent middle cerebral artery occlusion \[pMCAO\]) ([@bib13]), and we carried out diffusion-weighted imaging (DWI) at 2, 24, and 48 hr after the ischemic insult. In DWI, the ischemic lesion appears hypointense, consistent with a decrease in the apparent diffusion coefficient of water (ADC), which is a weighted average between the intracellular (assumed to be lower) and extracellular diffusion coefficients (assumed to be higher). The decrease in ADC reflects the changes in the ratio of intracellular and extracellular volume, because ischemia-induced energy impairment and membrane pump failure allow the osmotic drainage of water from extracellular to intracellular spaces that leads to cytotoxic edema ([@bib44]). The results obtained in control animals ([Figure S4](#mmc1){ref-type="supplementary-material"}A) showed that in males, the damaged area at 24 and 48 hr was larger than in females, which is in line with previous reports ([@bib40]). Next, we transplanted 16 adult male mice with microglia purified either from male (n = 8 M/M) or female mice (n = 8 F/M). [Figure 4](#fig4){ref-type="fig"}A shows the DWI of the transplanted mice at 2, 24, and 48 hr after ischemia. At 2 hr after the infarct, the sex of origin of the transplanted microglia did not influence the volume of the damage ([Figure S4](#mmc1){ref-type="supplementary-material"}B). This was expected because in our experience, changes in the damage size are not detectable at early phase after ischemia ([@bib13]). In the M/M group, the progression of the damage was significantly higher (+26% after 48 hr) than in the F/M group ([Figure 4](#fig4){ref-type="fig"}B), thus pointing to a protective action of the female microglia. Male microglia into female brain (n = 8) did not provide as clear and significant results ([Figure S4](#mmc1){ref-type="supplementary-material"}C).Figure 4Sex of Microglia Influence the Progression of Ischemic Stroke(A) Time-dependent evolution of infarct volume in permanent middle cerebral artery occlusion (pMCAO) mice. Diffusion-weighted imaging (DWI) representative of male mice transnasally administered with male (M/M) or female (F/M) microglia, taken at 2, 24, and 48 hr after pMCAO. The ischemic lesion is detectable as a hypointense area in the right cerebral hemisphere (delineated by the yellow dotted line). The image is representative of n = 8 animals.(B) Scatterplot showing the quantitative analysis of the brain damage volume determined by DWI measurements and expressed as percent change relative to the initial 2 hr value set to 100%. Solid lines represent mean ± SEM for M/M (n = 8) and F/M mice (n = 8). ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 by two-way ANOVA and Sidak's method for multiple comparisons.(C) Representative, low-magnification (×20) immunofluorescence analysis of coronal sections of brains excised from adult mice that had undergone pMCAO, stained for Iba1 (white), CD16/32 (green), Ym1 (red), and Hoechst 33258 (blue). M/M: male recipient transplanted with male microglia; F/M: male recipient transplanted with female microglia. Images are representative of n = 3 mice per experimental group and show the fluorescence images acquired in the areas indicated by red squares in the upper schematics. Scale bar: 10 μm.(D) Representative high-magnification (×100) confocal z stack projections of cells stained for Iba1 (white), CD16/32 (green), Ym1 (red), and Hoechst 33258 (blue) in mice that had undergone pMCAO. The pictures show the colocalization of pro- (CD16/32) and anti-inflammatory markers with Iba1-stained microglia. M/M: male recipient transplanted with male microglia; F/M: male recipient transplanted with female microglia. Images are representative of n = 3 mice per experimental group. Scale bar: 10 μm.(E) Graph columns show the mean ± SEM of fluorescence brightness for Ym1 (red channel) in Iba1-positive cells, measured in a double-blind manner. ^∗^p \< 0.05 by unpaired, two-tailed t test.

To determine the ability of exogenous microglia to migrate to the infarct site, we subjected mice transplanted with bioluminescent G4063 microglia to pMCAO. Bioluminescence imaging revealed that after pMCAO, a large amount of the bioluminescent, exogenous microglia accumulated in the vicinity of the infarct site ([Figure S4](#mmc1){ref-type="supplementary-material"}D). The phenotype of microglia at the lesion site was investigated by immunostaining of the pMCAO lesioned brain. We used Ab against Ym1 as a marker for microglia anti-inflammatory activation and against CD16/32 as a marker for pro-inflammatory activation ([Figure 4](#fig4){ref-type="fig"}C). Low-magnification confocal imaging of the fields of view surrounding the ischemic lesion revealed that Ym1 immunoreactivity was higher in brain samples obtained from the F/M animals. At higher magnification (×100), the immunofluorescence showed that both CD16/32 and Ym1 co-localized with Iba1 immunoreactivity ([Figure 4](#fig4){ref-type="fig"}D). Semiquantitative, double-blind analyses of the average fluorescence brightness in Iba1-positive cells surrounding the ischemic lesion showed Ym1 immunoreactivity significantly higher (+92%) in F/M versus M/M ([Figure 4](#fig4){ref-type="fig"}E). CD16/32 staining was comparable in both experimental groups ([Figure S4](#mmc1){ref-type="supplementary-material"}E).

Discussion {#sec3}
==========

The present study shows that microglia cells are sexually differentiated, as indicated by the sex-specific expression of a significant number of genes. Microglia cells maintain sex-specific expression independently by the circulating sex steroids, which was demonstrated by putting adult microglia in culture or by their transplant in the opposite sex. In addition, ovariectomy did not show very significant changes in microglia gene expression. The mechanism involved in microglia sexual differentiation remains to be determined. The fact that neonatal treatment of female brain with estrogens (using a protocol known to induce brain defemination) altered the expression of selected genes may suggest that similar to what was reported for neurons, the sex of microglia is determined at birth. Microglia are an autonomous self-proliferating population of cells that migrate from the yolk sac prior to hematopoiesis. Following brain colonization, these cells differentiate into microglia, and the formation of the blood-brain barrier prevents the infiltration of peripheral cells, at least under healthy conditions. Therefore, the masculinizing surge of testosterone might induce the differentiation of this cell population, because neonatal microglia express the estrogen receptor alpha ([@bib6], [@bib39]). Other authors studying microglia in embryos, neonates, and adult mice showed that there are precise temporal phases that characterize microglia development ([@bib25]), and that the immune reactivity of these cells is sexually differentiated very early in development ([@bib15]). In addition, during the first week postpartum in mice, there are sexual differences in the morphology and the number of these cells ([@bib23]), and microglia have an inflammatory morphology that converts to a largely ramified state occurring by the third week after birth when male defemination is completed. These observations have suggested that microglia in the neonatal brain are involved in more than a response to brain injury or inflammation; that is, microglia actively participate in the formation of specific brain circuitries by regulating a variety of developmental processes and physiological functions including synapse elimination, spinogenesis, spine elimination, and synaptic physiology ([@bib43]).

Our study suggests that the local neonatal synthesis of estrogen associated with the androgen surge from the male testis may not be a cause of transient activation of microglia but might have permanent (organizational) effects on these cells by inducing a sexual phenotype that is maintained in the adult animals. This would explain why male or female microglia have the tendency to maintain the same gene expression when transplanted in the opposite sex. Indeed, analogous to what occurs in neurons where their sensitivity and ability to respond to specific hormonal and environmental stimuli (activational effects) is permanently affected by the neonatal estrogen priming, our data suggest that in male microglia, the estrogen priming changes their immune capacity by enhancing their ability to react to inflammatory stimuli. These data are in agreement with a very recent study aimed at comparing the male and female microglia transcriptome in relation with the stage of development ([@bib15]).

We do not know what the teleological meaning of this sexual differentiation is; certainly, our studies show that this biological event has functional repercussions on the damage caused from acute cerebral ischemia (MCAO) ([Figure 4](#fig4){ref-type="fig"}). It is well known that the damage induced by MCAO is significantly higher in males than in females, and several studies have debated whether this is due to a lower susceptibility of female neurons to ischemia or to differences in the evolution of the neuroinflammatory response ([@bib30]). The findings reported here that female microglia are better apt than male microglia to reduce the ischemic damage also when transplanted in males highlight an intrinsic sex-specific microglia phenotype that might be independent from the hormonal environment. This is in line with the observation that in humans, males have a higher incidence of stroke and poorer outcomes afterward ([@bib14]). However, we cannot definitively conclude that estrogens do not influence microglia activity, because aromatase is expressed in the male brain and may convert locally the circulating testosterone into estradiol ([@bib28]).

Our results point to microglia as major actors in the evolution of the ischemic insult; this is in accordance with prior literature, as our observations were conducted at 24 and 48 hr after ischemia. Morphological, immunohistochemical, MRI-based, and pharmacological studies have shown that in the first 72 hr after ischemia, the CNS resident microglia control the course of inflammation, generating anti-inflammatory or repair molecules in the insult area ([@bib12], [@bib36]). Additionally, microglia participate in attracting peripheral immune cells that populate the damaged area at later times ([@bib12]). At this point, it is possible that in females, the presence of circulating estrogens limits the damage caused by an excessive inflammatory response, because female monocytic cells were shown to better transit toward the anti-inflammatory phenotype ([@bib47]) and were likely able to confine the tissue damage induced by the hypoxic stimulus, possibly by virtue of the limited expression of genes encoding inflammatory proteins. Interestingly, when we transplanted male microglia into female brains, we did not observe an increase in the ischemic area with time. This might be because the female resident microglia buffered the effects of the grafted cells.

Neuropsychiatric or neurological diseases may manifest in a large percentage of the population (approximately 25% of individuals suffer from brain disorders in their lifespan) with a pattern of susceptibility that is associated with sex. Females are more affected by diseases that occur during adulthood, whereas males are particularly vulnerable to life-long illnesses of neurodevelopmental origin. Considering the number of studies underscoring the relevance of inflammation in brain disturbances, the finding of a sex difference in male and female susceptibility to neuroinflammation provides a basis for a sex-related approach to therapy that must be based on a better understanding of the relationships among the endocrine, immune, and nervous systems in young and adult individuals.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

Animal studies were carried out at the Department of Pharmacological and Biomolecular Sciences. All animal experimentation was carried out in accordance with the ARRIVE and European Guidelines for Animal Care. All animal experiments were approved by the Italian Ministry of Research and University (permission numbers: 12-12-30012012, 547/2015, 479/2015) and controlled by a departmental panel of experts.

C57BL/6 and CX3CR1-GFP mice at 3 months of age were supplied by Charles River (Charles River Laboratories, Calco, Italy). Both male and female mice were used throughout experiments as described earlier. Animals were allowed access to food and water *ad libitum* and kept in temperature-controlled facilities on a 12-hr light and dark cycle. More details are available in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Pharmacological Manipulations {#sec4.2}
-----------------------------

E~2~ (Sigma-Aldrich, Italy) was administered by a 100 μL s.c. injection of 5 μg/kg E~2~ (which results in circulating E~2~ levels comparable with those at proestrus \[[@bib5]\]) dissolved in corn oil by overnight (o/n) stirring in the dark at room temperature; control animals received corn oil injection alone. E~2~ benzoate was administered by a s.c. injection of 5 μg in 50 μL of corn oil; control animals received corn oil alone.

Microglia Sorting {#sec4.3}
-----------------

Isolation of microglia from the whole brains of adult mice was performed as described in [@bib33]. More details are available in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

PLX3397 Administration {#sec4.4}
----------------------

8.3 mg of PLX3397 was dissolved in 1 mL of 5% DMSO + 45% polyethylene glycol 300 (PEG300) + ddH~2~O (double-distilled water) solution. Prior to tsn administration, animals were anesthetized with s.c. injection of 50 μL solution of ketamine (93.6 mg/kg, Ketavet 100; Intervet, Milan, Italy) and xylazine (7.2 mg/kg, Rompun; Bayer, Milan, Italy). More details are available in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Cell Cultures {#sec4.5}
-------------

Primary neuronal cultures were obtained from the hippocampi of 18-day-old fetal Sprague Dawley rats of both sexes (Charles River Italia). Neurons were transfected at 7 days *in vitro* (*DIV7*) using the calcium-phosphate method with 2 μg of EGFP plasmid. At *DIV10* microglia were isolated from the brain of adult mice and seeded over rat neurons with a microglia:neuron ratio of 1:10. At *DIV14*, cells were either processed for immunocytochemistry or resuspended in TRIzol reagent (Invitrogen, Milan, Italy) and processed for RNA preparation.

Morphological Analysis of Iba1-Stained Microglia {#sec4.6}
------------------------------------------------

Three images of six slides per experimental condition were taken. The size of the fields analyzed was 173 μm × 218 μm. Morphological analyses were performed in a double-blind manner as previously described ([@bib3]). ImageJ software was used to measure immunoreactivity through a threshold method, and the number of positive pixels and the extension of area of interest were used to determine the fractional area covered by the specific signal.

Brain Masculinization {#sec4.7}
---------------------

Pregnant C57BL/6 mice were individually housed after pups' birth. All pups within a litter were subcutaneously injected with vehicle (50 μL corn oil) or treatment (5 μg E~2~ benzoate in 50 μL corn oil) ([@bib49]) at post-natal day 2 (P2), P5, and P8. At P21, females and males were housed in separate cages. At 10--14 weeks of age, vaginal smears were carried out to study the ability of the females to cycle.

MRI Analysis {#sec4.8}
------------

Brain infarct size was visualized by DWI at 2, 24, and 48 hr after MCAO using a 4.7 T, vertical super-wide bore magnet of a Bruker Avance II spectrometer with microimaging accessory. More details are available in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Statistical Analyses {#sec4.9}
--------------------

Statistical analysis of RNA-seq data were carried out using the CuffDiff ([@bib42]) software. A t test was used to calculate the p value for differential expression. A threshold of 0.01 was applied to FDR-adjusted p values (q values) in order to select the DEGs to use in downstream analyses. Cluster analyses were performed with the Genesis software tool (<https://genome.tugraz.at/genesisclient/genesisclient_description.shtml>) to log-transform, normalize, and center gene expressions, and populations and genes were clustered by Pearson correlation. Overrepresentation analysis (ORA) on DEG lists was performed using Enrichr for enrichment analysis. The mouse genome was used as background list. Biological processes, molecular functions, and KEGG pathways were investigated focusing on enriched terms with a Benjamini-adjusted p value less than 0.05.

Statistical significance of the other reported data were calculated using Prism 7 software (GraphPad); unless otherwise indicated in the figure legend, one-way ANOVA for single-treatment comparisons or two-way ANOVA for multiple treatment comparisons was applied. A p value less than 0.05 was considered as statistically significant.

Data and Software Availability {#app1}
==============================

The accession number for the RNA-seq data reported in this paper is NCBI Sequence Read Archive: SRP104620.

Supplemental Information {#app3}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S4Document S2. Article plus Supplemental Information
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